Try our Advanced Search for more refined results
January 14, 2010
Daiichi Sankyo Inc. et al v. Impax Laboratories Inc.
Case Number:
1:10-cv-00032
Court:
Nature of Suit:
Judge:
Firms
Companies
- Daiichi Sankyo Co.
- Genzyme Corp.
- Glenmark Pharmaceuticals Ltd.
- Impax Laboratories, Inc.
- Lupin Ltd.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 30, 2011
Impax Settles With Daiichi, Genzyme Over Generic Welchol
Impax Laboratories Inc. said Thursday it had resolved patent litigation brought by Daiichi Sankyo Inc and Genzyme Corp. in Delaware over cholesterol drug Welchol, striking a deal that will allow Impax to launch a generic version in 2015.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login